| |
Steven S. Rosenfeld, MD, PhD John and Elizabeth Harris Professor and of Neurology Chief, Division of Neuro-Oncology
Education:
- MD: Northwestern University
- PhD: University of Chicago (Biophysics)
- Residency: Duke University
- Fellowship: Duke University (Neuro-Oncology)
Board Certification: Neurology, Neuroimaging
Insurance: Aetna, CIGNA, Empire BC/BS-Wellchoice & Unicare, Neighborhood Health Providers, Oxford, PHS/Healthnet, United Healthcare, Medicare *Please verify insurance participation with the physician's office when making an appointment.

» Brain Tumor Center
Dr. Rosenfeld is the John and Elizabeth Harris Professor of Neurology, Head of the Division of Neuro-Oncology in the Department of Neurology, College of Physicians and Surgeons of Columbia University, and Co-Director of the Brain Tumor Center at the New York-Presbyterian Hospital. After completing his training, he joined the medical school faculty at the University of Alabama at Birmingham , and assumed directorship of its Brain Tumor Program in 1995. Under his leadership, the UAB Brain Tumor Program underwent a marked expansion in both clinical and translational research, enabling it to achieve a position of national prominence. This culminated in Dr. Rosenfeld's being awarded a Brain Cancer Specialized Center of Research Excellence (SPORE) grant by the National Cancer Institute in 2002--one of only two nation-wide. Dr. Rosenfeld's research, which has been funded by the National Cancer Institute and the National Institute of Neurological Diseases and Stroke, focuses on novel ways of pharmacologically-blocking brain tumor growth and invasiveness by targeting the molecular motors that drive mitosis and cell motility. He is a Fellow of the American Neurological Association, has served as a member of the Editorial Board of the Journal of Biological Chemistry, is a peer reviewer for over 15 scientific journals, and is a member of the Developmental Therapeutics study section. He has also served as the Educational Program Director for the Society for Neuro-Oncology (1999) and as a member of the NCI/NINDS Progress Review Group in Neuro-Oncology.
|

© 2004 The Neurological Institute of New York • 710 W 168th St, New York, NY 10032
Department of Neurology | Columbia University Medical Center | Last updated:
August 28, 2009
| Comments |
|
|